FDA Considers Approval of Cancer-causing Contraception for Sale Over the Counter (RAN)

On May 10, fears of chemical abortion restriction is causing the FDA to consider approval of the cancer-causing contraceptive pill for sale over the counter, without a doctor’s prescription. A final decision from the FDA is expected this summer.

The World Health Organization has listed oral contraceptives as Group 1 carcinogens along with plutonium, causing increased risk of breast cancer. Peer reviewed evidence presented to the Supreme Court demonstrates the pill increases the risk of the most aggressive, triple-negative breast cancer in girls 18 and under by 6.4 times. Medical ethicist, Rev. Jim Harden says, “A decision by the FDA to expose women and girls to a high-risk hormone therapy without physician oversight or parental guidance recklessly holds a woman’s health hostage to a political narrative.”

To serve women and save lives go to realabortionnews.com/donate.

Leave A Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.